Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has received a new purchase order for 60,000 units of its Sky Premium Life products from Pharmalink under the existing exclusive distribution agreement for the United Arab Emirates (UAE) market. This marks the third consecutive purchase order from Pharmalink, bringing cumulative orders to 270,000 units since the partnership's inception in June 2024.

Sustained and Growing UAE Demand

This latest order follows a clear pattern of accelerating demand in the UAE market. In June 2024, Cosmos Health signed an exclusive distribution agreement with Pharmalink and secured an initial purchase order of 130,000 units. Following the complete sell-out of that initial order, Pharmalink placed a follow-up order for 80,000 units in May 2025. The Company has now received its third purchase order for an additional 60,000 units, underscoring the sustained consumer demand and commercial momentum of the Sky Premium Life brand across the UAE.

Pharmalink, led by CEO Dr. Abdul Rauf Jabour, is one of the largest healthcare organizations in the UAE, with over 30 years of experience, a workforce of approximately 1,400 employees, a network of more than 120 partners, a portfolio of over 430 brands, and access to more than 3,000 pharmacies, including its own MEDICINA chain of approximately 200 pharmacies. Pharmalink is responsible for all sales, marketing, regulatory affairs, logistics, and distribution activities related to Sky Premium Life products in the UAE.

Strategic Middle East Presence Amid Geopolitical Resilience

This order further demonstrates Cosmos Health's ability to grow its commercial footprint in the Middle East despite the broader regional geopolitical environment. The UAE, and Dubai and Abu Dhabi in particular, represent some of the most affluent and fastest-growing nutraceutical markets globally, and the Company's continued traction with Pharmalink reflects the resonance of the Sky Premium Life brand with health-conscious consumers in the region.

On Track Toward 3 Million Unit Cumulative Goal

With 270,000 cumulative units ordered to date, the Company continues to advance toward its objective of surpassing 3 million units in cumulative orders over the first five years of its partnership with Pharmalink. The Company expects purchase order volumes to continue growing as Sky Premium Life brand awareness expands across Pharmalink's extensive distribution network.